By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Syndax Pharmaceuticals Inc. 

400 Totten Pond Road
Suite 110
Waltham  Massachusetts  02451  U.S.A.
Phone: 781-419-1400 Fax: 781-419-1420


SEARCH JOBS



Segment
Start Up





Company News
Syndax Prices Public Offering Of Common Stock 5/25/2017 8:09:40 AM
Syndax Announces Proposed Public Offering Of Common Stock 5/24/2017 11:17:20 AM
Syndax Announces Results From Phase II ENCORE 601 Trial Of Entinostat In Combination With KEYTRUDA (Pembrolizumab) For The Treatment Of Advanced Melanoma 5/18/2017 11:22:53 AM
Syndax Announces Advancement Of ENCORE 601 In Non-Small Cell Lung Cancer Patients With Disease Progression On Or After PD-1 Therapies 5/17/2017 11:14:11 AM
Syndax Reports First Quarter 2017 Financial Results And Provides Clinical And Business Update 5/9/2017 10:58:29 AM
Syndax To Announce First Quarter 2017 Financial Results And Host Conference Call And Webcast On May 8, 2017 5/1/2017 11:08:17 AM
Syndax Announces Expansion Of Immuno-Oncology Collaboration Evaluating Entinostat In Combination With KEYTRUDA (Pembrolizumab) For The Treatment Of Colorectal Cancer 4/27/2017 11:20:01 AM
Syndax Adds Biopharmaceutical Industry Leader Keith A. Katkin To Board Of Directors 4/4/2017 12:06:08 PM
Syndax To Announce Fourth Quarter And Year-End 2016 Financial Results And Host Conference Call And Webcast On March 2, 2017 2/16/2017 8:17:20 AM
Syndax Appoints Richard P. Shea As Chief Financial Officer 2/9/2017 8:17:54 AM
123456789
//-->